Intellia Therapeutics Inc
Statements
Cash Flow
Intellia Therapeutics Inc (NTLA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -200 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.6 | -14 | -11 | -16 | -17 | -21 | -18 | -22 | -12 | -8.5 | -21 | -28 | -25 | -29 | -39 | 57 | -29 | -40 | -52 | -53 | -65 | -55 | -80 | -85 | -79 | -90 | -109 | -90 | -101 | -93 | -121 | -58 | -85 | -85 | -149 | -100 | -77 | -69 | -117 | -200 | -464 | |
| 0.3 | 0.4 | 0.7 | 0.7 | 0.8 | 0.8 | 1.0 | 1.1 | 1.2 | 1.2 | 1.3 | 1.3 | 1.4 | 1.6 | 1.5 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.8 | 1.9 | 1.8 | 1.8 | 2.0 | 2.0 | 2.1 | 2.2 | 2.3 | 2.5 | 2.5 | 2.6 | 2.6 | 2.6 | 2.5 | 2.5 | 4.9 | 0.4 | 2.2 | 4.3 | 12 | |
| 2.1 | 2.0 | 2.6 | 2.8 | 3.2 | 6.6 | 4.1 | 4.9 | 4.5 | 3.6 | 4.6 | 4.4 | 3.1 | 3.0 | 4.2 | 4.8 | 5.4 | 5.6 | 6.4 | 11 | 15 | 15 | 18 | 23 | 25 | 25 | 27 | 36 | 35 | 35 | 34 | 41 | 40 | 40 | 22 | 22 | 20 | 91 | 13 | 32 | 155 | |
| 2.1 | 6.7 | 2.6 | 2.9 | 3.3 | 15 | 4.1 | 4.9 | 4.5 | 3.7 | 4.6 | 4.4 | 3.1 | 3.0 | 4.2 | 4.8 | 5.4 | 5.6 | 6.4 | 12 | 15 | 13 | 78 | 26 | 35 | 33 | 30 | 36 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -2.4 | -6.3 | -2.1 | -3.7 | -5.6 | -4.8 | -1.5 | -6.2 | 4.6 | 6.3 | -4.2 | -6.8 | -5.1 | -4.5 | -12 | 84 | -7.8 | -6.0 | -15 | 1.9 | -13 | 3.2 | -18 | -17 | -5.6 | -13 | -37 | -5.0 | -14 | 3.1 | -30 | 30 | 9.9 | 2.0 | -59 | -20 | 4.4 | 0.5 | -37 | -33 | -65 | |
| 0.6 | 3.4 | 4.2 | 1.3 | 2.3 | 2.4 | 1.9 | 0.9 | 2.0 | 1.6 | 1.5 | 0.9 | 1.7 | 2.6 | 0.8 | 1.0 | 0.7 | 1.0 | 2.4 | 2.9 | 4.5 | 2.9 | 46 | 4.0 | 4.2 | 3.9 | 3.8 | 4.3 | 4.3 | 1.5 | 2.5 | 1.0 | 1.3 | 1.0 | 0.7 | 0.2 | 0.0 | 0.1 | 0.1 | 1.9 | 2.1 | |
| -0.6 | -3.4 | -4.2 | -1.3 | -2.3 | -2.4 | -1.9 | -0.9 | -2.0 | -256 | 5.7 | 23 | -32 | 28 | 57 | 93 | -154 | -211 | -26 | 33 | -399 | -159 | 47 | 95 | 48 | -30 | -122 | -35 | 80 | 46 | 5.9 | -24 | -7.7 | 152 | 94 | 107 | -0.7 | 28 | 66 | -75 | 18 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -1.7 | 0.1 | 0.0 | 0.4 | 0.4 | 141 | 6.7 | 1.2 | 2.2 | 30 | 4.0 | 6.5 | 46 | 20 | 4.9 | 132 | 0.6 | 234 | 59 | 7.1 | 669 | 1,127 | 47 | 5.9 | 24 | 506 | 2.2 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -1.9 | 0.3 | 0.0 | 0.4 | 0.4 | 142 | 6.7 | 1.2 | 2.2 | 30 | 4.0 | 6.5 | 46 | 20 | 4.9 | 132 | 0.6 | 234 | 59 | 7.1 | 669 | 2.3 | 47 | 5.9 | 24 | 506 | 2.2 | 2.5 | 19 | 106 | 60 | 41 | 82 | 2.3 | 0.0 | 15 | 115 | 2.0 | 34 | 230 | 380 | |
| -10 | -18 | -16 | -17 | -19 | 118 | -13 | -22 | -12 | -234 | -12 | 2.0 | -11 | 19 | 24 | 283 | -182 | -17 | -19 | -13 | 204 | -213 | 15 | 16 | -6.9 | 386 | -229 | -122 | -2.8 | 59 | -55 | -41 | -10 | 69 | -55 | 22 | 37 | -38 | -21 | -46 | -68 | |
| -8.2 | -18 | -16 | -17 | -19 | -24 | -20 | -23 | -14 | -10 | -23 | -29 | -27 | -31 | -39 | 56 | -29 | -41 | -55 | -56 | -70 | -58 | -126 | -89 | -83 | -94 | -113 | -95 | -106 | -95 | -123 | -59 | -86 | -86 | -150 | -100 | -77 | -69 | -117 | -202 | -466 |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.